ISO Changes: Managing Risk
The new ISO 9001:2015 standard emphasizes risk assessment. Medical shops with ISO 13485 certification already manage this.
Share
Hwacheon Machinery America, Inc.
Featured Content
View More
ECi Software Solutions, Inc.
Featured Content
View More
Takumi USA
Featured Content
View More
This is just a small portion of the process failure mode and effects analysis (PFMEA) document that Protomatic developed. It identifies more than 300 potential failure modes and offers procedures to mitigate those risks.
After the end of September 2018, a certificate to ISO 9001:2008 will no longer be valid. One change in its replacement ISO 9001:2015 is a requirement to establish procedures for comprehensive risk management. Shops with medical ISO 13485 certification already manage this.
Failure mode and effects analysis (FMEA) is one common method of risk identification and mitigation, although it is sometimes referred to differently from company to company. Protomatic, a Dexter, Michigan, prototype machining and custom short-run production facility serving the medical, automotive, military and aerospace industries, refers to its as PFMEA—process failure mode and effects analysis.
Learning about the risk management procedures this shop has put in place might serve as a good model for other, non-medical shops that will be working toward becoming registered to the updated standard. Learn more.
Related Content
-
The Producto Group Appoints New Member to Board of Directors
Dean Schauer, the newest appointee to the company’s board of directors, is the current CEO and president of Confluent Medical Technologies.
-
Vollmer Ultrasonic Cleaning, Deburring System Provides Process Reliability
IMTS 2024: The UltraTec Ultrasonic A25 cleans and deburrs small and delicate components, making it well suited for applications in heavily regulated sectors with challenging demands.
-
EDM, Laser Micromachining and More at GF Medical Demo Center
At GF’s Medical Center of Competence, the company shows off EDM and laser features that could make a large impact on medical manufacturing — and elsewhere.
